Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules.

Science (New York, N.Y.)·2024
Same author

Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome.

Journal of medical genetics·2023
Same author

Students' and staffs' views and experiences of asymptomatic testing on a university campus during the COVID-19 pandemic in Scotland: a mixed methods study.

BMJ open·2023
Same author

Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.

European journal of human genetics : EJHG·2022
Same author

Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

JNCI cancer spectrum·2022
Same author

Fast and automated biomarker detection in breath samples with machine learning.

PloS one·2022

相关实验视频

Updated: Jul 18, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K

通过液体活检重新定义精确放射疗法.

D B McLaren1, T J Aitman2

  • 1Edinburgh Cancer Centre, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK. duncan.mclaren@ed.ac.uk.

British journal of cancer
|August 19, 2023
PubMed
概括
此摘要是机器生成的。

精确放射疗法提高了准确性,但没有改善结果. 分析无细胞DNA以实现个性化剂量以及精确的输送,将重新定义放射治疗的精度,以更好地控制瘤并降低毒性.

更多相关视频

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.0K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.1K

相关实验视频

Last Updated: Jul 18, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.0K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.1K

科学领域:

  • 辐射瘤学 辐射瘤学
  • 分子诊断学 分子诊断学
  • 癌症治疗 治疗 癌症治疗

背景情况:

  • 精密辐射疗法提供了毫米以下精度的辐射.
  • 目前的方法不考虑瘤或正常组织反应的个体变化.
  • 这种限制阻碍了最大的瘤控制和最佳的毒性最小化.

研究的目的:

  • 建议重新定义精确放射治疗的方法.
  • 将基于无细胞DNA分析的个性化剂量与精确的辐射输送相结合.
  • 为了提高放射治疗的有效性,最大限度地控制瘤并最大限度地减少毒性.

主要方法:

  • 审查当前的精确放射治疗技术.
  • 探索用于个性化剂量策略的无细胞DNA分析.
  • 精确的输送和个性化剂量的概念整合.

主要成果:

  • 精密放射治疗的准确性已经确立,但不足以达到最佳的结果.
  • 无细胞DNA分析为评估个体治疗反应提供了一种可行的方法.
  • 将精确的输送与个性化剂量相结合,呈现出一种新的范式.

结论:

  • 重新定义精确放射治疗需要将个性化剂量与准确的输送相结合.
  • 无细胞DNA分析是个性化放射治疗的关键生物标志物.
  • 这种综合方法有望显著提高癌症治疗效率和患者安全.